These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36822638)

  • 41. "Variability of within-breath reactance in COPD patients and its association with dyspnoea." Bernt B. Aarli, Peter M.A. Calverley, Robert L. Jensen, Tomas M.L. Eagan, Per S. Bakke and Jon A. Hardie. Eur Respir J 2015; 45: 625-634.
    Eur Respir J; 2017 Jan; 49(1):. PubMed ID: 28122860
    [No Abstract]   [Full Text] [Related]  

  • 42. "Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics." M. Badran, A. Khalyfa, A.C. Ericsson, C. Puech, Z. McAdams, S.B. Bender and D. Gozal.
    Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 37105588
    [No Abstract]   [Full Text] [Related]  

  • 43. "Dead space: the physiology of wasted ventilation." H. Thomas Robertson. Eur Respir J 2015; 45: 1704-1716.
    Eur Respir J; 2015 Oct; 46(4):1226. PubMed ID: 26424526
    [No Abstract]   [Full Text] [Related]  

  • 44. "GINA 2015: the latest iteration of a magnificent journey." Jean Bousquet and Marc Humbert. Eur Respir J 2015; 46: 579-582.
    Eur Respir J; 2015 Dec; 46(6):1854. PubMed ID: 26621898
    [No Abstract]   [Full Text] [Related]  

  • 45. "Number needed to treat: enigmatic results for exacerbations in COPD." Samy Suissa.
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29903826
    [No Abstract]   [Full Text] [Related]  

  • 46. First report of
    Halleen F; Havenga M; McLeod A; Mostert L
    Plant Dis; 2022 Aug; ():. PubMed ID: 35971263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "ERS and tobacco harm reduction." Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman, Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco Control Committee, on behalf of the ERS.
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 32001496
    [No Abstract]   [Full Text] [Related]  

  • 48. "Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes." Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson.
    Eur Respir J; 2020 Mar; 55(3):. PubMed ID: 32217620
    [No Abstract]   [Full Text] [Related]  

  • 49. Regional deposition of inhaled hygroscopic aerosols: in vivo SPECT compared with mathematical modeling.
    Finlay WH; Stapleton KW; Chan HK; Zuberbuhler P; Gonda I
    J Appl Physiol (1985); 1996 Jul; 81(1):374-83. PubMed ID: 8828688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum.
    Am J Hosp Palliat Care; 2018 Jan; ():1049909118769509. PubMed ID: 29649891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of montelukast-desloratadine combination on early and late asthma responses Davis BE, Illamperuma C, Gauvreau GM, et al. Single-dose desloratadine and montelukast and allergen-induced late airway responses. Eur Respir J 2009;33(6):1302-308.
    Antoniu SA
    Expert Opin Pharmacother; 2009 Oct; 10(15):2577-9. PubMed ID: 19735214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The divorce of Sporothrix and Ophiostoma: solution to a problematic relationship.
    de Beer ZW; Duong TA; Wingfield MJ
    Stud Mycol; 2016; 83():165-91. PubMed ID: 27616802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hot topics from the Assemblies.
    Breathe (Sheff); 2015 Mar; 11(1):81-2. PubMed ID: 26306109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Lung biopsy in interstitial lung disease: balancing the risk of surgery and diagnostic uncertainty." Vincent Cottin. Eur Respir J 2016; 48: 1274-1277.
    Eur Respir J; 2016 Dec; 48(6):1819. PubMed ID: 27903698
    [No Abstract]   [Full Text] [Related]  

  • 55. "Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis." Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776-1784.
    Eur Respir J; 2016 Aug; 48(2):593. PubMed ID: 27478193
    [No Abstract]   [Full Text] [Related]  

  • 56. "Electronic nicotine delivery systems (ENDS): the beginning of the end or the end of the beginning?" Francesco Blasi and Brian Ward. Eur Respir J 2014; 44: 585-588.
    Eur Respir J; 2015 Mar; 45(3):861. PubMed ID: 25726547
    [No Abstract]   [Full Text] [Related]  

  • 57. "Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice." Stephen Y. Chan and Lewis J. Rubin.
    Eur Respir Rev; 2018 Mar; 27(147):. PubMed ID: 29367412
    [No Abstract]   [Full Text] [Related]  

  • 58. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF/MS)-based identification of pathogens from positive blood culture bottles.
    Lagacé-Wiens P
    Methods Mol Biol; 2015; 1237():47-55. PubMed ID: 25319778
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: is Europe behind?" Irene M. Lang and Hiromi Matsubara.
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31649150
    [No Abstract]   [Full Text] [Related]  

  • 60. Pulmonary Alveolar Microlithiasis: A novel patient and brief review of the literature.
    de Oliveira Mekonnen A; Schwerk N; Schütz K; Schramm L; Dreissig A; Grewendorf S; Sukdolak C; Dopfer C; Auber B; von Hardenberg S; Happle C
    Klin Padiatr; 2022 Sep; 234(5):317-319. PubMed ID: 35139546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.